Position
Corecam AG in Pfizer Inc
Back to the book · All holders of PFE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $521.8K$24.90 → $28.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 164.1K | $4.09M | — | — | — | 4.0% |
| Q1 2026 | 164.1K | $4.61M | $28.08 | $521.8K | −$0 | 3.9% |